BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leodolter A, Nocon M, Kulig M, Willich SN, Malfertheiner P, Labenz J. Gastro esophageal reflux disease is associated with absence from work: Results from a prospective cohort study. World J Gastroenterol 2005; 11(45): 7148-7151 [PMID: 16437662 DOI: 10.3748/wjg.v11.i45.7148]
URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7148.htm
Number Citing Articles
1
R. C. V. da Silva, C. C. de Sá, Á. O. Pascual-Vaca, L. H. de Souza Fontes, F. A. M. Herbella Fernandes, R. A. Dib, C. R. Blanco, R. A. Queiroz, T. Navarro-Rodriguez. Increase of lower esophageal sphincter pressure after osteopathic intervention on the diaphragm in patients with gastroesophageal refluxDiseases of the Esophagus 2013; 26(5): 451 doi: 10.1111/j.1442-2050.2012.01372.x
2
John W. Jacobs. The Esophagus2021; : 1 doi: 10.1002/9781119599692.ch1
3
Ravishankar Jayadevappa, Sumedha Chhatre, Mark Weiner. Gastro-oesophageal acid-related disease, co-morbidity and medical care costChronic Illness 2008; 4(3): 209 doi: 10.1177/1742395308092817
4
Catarina Jansson, Michael Wiberg, Kristina Alexanderson. Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based studyScandinavian Journal of Gastroenterology 2013; 48(1): 17 doi: 10.3109/00365521.2012.737359
5
Josep Darbà, Lisette Kaskens, Pedro Plans, Jose Ignasi Elizalde, Montserrat Coma, Rosario Cuomo, Luigi Santoiemma, Jan Geldmacher. Epidemiology and societal costs of gastroesophageal reflux disease and Barrett’s syndrome in Germany, Italy and SpainExpert Review of Pharmacoeconomics & Outcomes Research 2011; 11(2): 225 doi: 10.1586/erp.11.5
6
M. NOCON, T. KEIL, S. N. WILLICH. Prevalence and sociodemographics of reflux symptoms in Germany – results from a national surveyAlimentary Pharmacology & Therapeutics 2006; 23(11): 1601 doi: 10.1111/j.1365-2036.2006.02924.x
7
Rafael Corrêa Vieira da Silva, Tomás Navarro-Rodríguez, Ángel Oliva Pascual-Vaca, Cleofás Rodríguez Blanco. La enfermedad por ref ujo gastroesofágico y la unión esofagogástrica. Revisión de la literaturaOsteopatía Científica 2010; 5(3): 84 doi: 10.1016/S1886-9297(10)70016-3
8
K. MONKEMULLER, H. NEUMANN, M. NOCON, M. VIETH, J. LABENZ, S. N. WILLICH, M. STOLTE, M. HOCKER, D. JASPERSEN, T. LIND, P. MALFERTHEINER. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro‐oesophageal reflux disease: a matched case–control studyAlimentary Pharmacology & Therapeutics 2008; 28(4): 491 doi: 10.1111/j.1365-2036.2008.03769.x
9
M. Rezailashkajani, D. Roshandel, S. Shafaee, M.R. Zali. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in IranDigestive and Liver Disease 2008; 40(6): 412 doi: 10.1016/j.dld.2008.01.014